These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4084247)

  • 1. Targeting of synthetically glycosylated human placental glucocerebrosidase.
    Murray GJ; Doebber TW; Shen TY; Wu MS; Ponpipom MM; Bugianesi RL; Brady RO; Barranger JA
    Biochem Med; 1985 Oct; 34(2):241-6. PubMed ID: 4084247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectin-specific targeting of beta-glucocerebrosidase to different liver cells via glycosylated liposomes.
    Das PK; Murray GJ; Zirzow GC; Brady RO; Barranger JA
    Biochem Med; 1985 Feb; 33(1):124-31. PubMed ID: 3994697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The uptake of native and desialylated glucocerebrosidase by rat hepatocytes and Kupffer cells.
    Furbish FS; Steer CJ; Barranger JA; Jones EA; Brady RO
    Biochem Biophys Res Commun; 1978 Apr; 81(3):1047-53. PubMed ID: 666784
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhanced macrophage uptake of synthetically glycosylated human placental beta-glucocerebrosidase.
    Doebber TW; Wu MS; Bugianesi RL; Ponpipom MM; Furbish FS; Barranger JA; Brady RO; Shen TY
    J Biol Chem; 1982 Mar; 257(5):2193-9. PubMed ID: 7061417
    [No Abstract]   [Full Text] [Related]  

  • 5. Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation.
    Furbish FS; Steer CJ; Krett NL; Barranger JA
    Biochim Biophys Acta; 1981 Apr; 673(4):425-34. PubMed ID: 6784774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the pharmacological properties of carbohydrate remodeled recombinant and placental-derived beta-glucocerebrosidase: implications for clinical efficacy in treatment of Gaucher disease.
    Friedman B; Vaddi K; Preston C; Mahon E; Cataldo JR; McPherson JM
    Blood; 1999 May; 93(9):2807-16. PubMed ID: 10216074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy in Gaucher's disease: a rapid, high-yield method for purification of glucocerebrosidase.
    Dale GL; Beutler E
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4672-4. PubMed ID: 1070017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The uptake of agalacto-glucocerebrosidase by rat hepatocytes and Kupffer cells.
    Steer CJ; Furbish FS; Barranger JA; Brady RO; Jones EA
    FEBS Lett; 1978 Jul; 91(2):202-5. PubMed ID: 680122
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the turnover of exogenous mannose-terminal glucocerebrosidase in rat liver lysosomes.
    Murray GJ; Oliver KL; Jin FS; Brady RO
    J Cell Biochem; 1995 Feb; 57(2):208-17. PubMed ID: 7759558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro.
    Dale GL; Kuhl W; Beutler E
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):473-5. PubMed ID: 284362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of the targeting of mannose-terminal glucocerebrosidase. Predominant uptake by liver endothelial cells.
    Bijsterbosch MK; Donker W; van de Bilt H; van Weely S; van Berkel TJ; Aerts JM
    Eur J Biochem; 1996 Apr; 237(2):344-9. PubMed ID: 8647071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoelectron microscopic localization of mannose-terminal glucocerebrosidase in lysosomes of rat liver Kupffer cells.
    Murray GJ; Jin FS
    J Histochem Cytochem; 1995 Feb; 43(2):149-58. PubMed ID: 7822772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectin-specific targeting of lysosomal enzymes to reticuloendothelial cells.
    Murray GJ
    Methods Enzymol; 1987; 149():25-42. PubMed ID: 3695962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Gaucher's disease with liposome-entrapped glucocerebroside: beta-glucosidase.
    Belchetz PE; Crawley JC; Braidman IP; Gregoriadis G
    Lancet; 1977 Jul; 2(8029):116-7. PubMed ID: 69198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of lysosomal glucocerebrosidase activity in mouse liver using a fluorescence-activated cell sorter assay.
    Chan KW; Waire J; Simons B; Karey K; Fung J; Copeland D; Andrews L
    Anal Biochem; 2004 Nov; 334(2):227-33. PubMed ID: 15494128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that influence the uptake and turnover of glucocerebrosidase and alpha-galactosidase in mammalian liver.
    Pentchev PG; Kusiak JW; Barranger JA; Furbish FS; Rapoport SI; Massey JM; Brady RO
    Adv Exp Med Biol; 1978; 101():745-52. PubMed ID: 208371
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.
    Barton NW; Furbish FS; Murray GJ; Garfield M; Brady RO
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1913-6. PubMed ID: 2308952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of oligosaccharide modification in glucocerebrosidase, a membrane-associated lysosomal hydrolase.
    Van Weely S; Aerts JM; Van Leeuwen MB; Heikoop JC; Donker-Koopman WE; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1990 Aug; 191(3):669-77. PubMed ID: 2143986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enzyme replacement therapy of patients with lysosomal storage disease].
    Takada G; Takahashi T
    Nihon Rinsho; 1995 Dec; 53(12):3077-82. PubMed ID: 8577062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.
    Brady RO; Pentchev PG; Gal AE; Hibbert SR; Dekaban AS
    N Engl J Med; 1974 Nov; 291(19):989-93. PubMed ID: 4415565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.